Want to see IN:ALBERTDAVD full AI Analyst Report?
ALBERTDAVD Stock Chart & Stats
₹788.40
-₹9.85(-0.75%)
At close: 4:00 PM EST
₹788.40
-₹9.85(-0.75%)
Day’s Range― - ―
52-Week Range₹581.30 - ₹925.00
Previous CloseN/A
Volume3.46K
Average Volume (3M)1.52K
Market Cap
₹4.90B
Enterprise Value₹1.07K
Total Cash (Recent Filing)₹2.58B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.0
Beta1.04
Next Earnings
Nov 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.58%
Share Statistics
EPS (TTM)39.54
Shares Outstanding5,707,162
10 Day Avg. Volume599
30 Day Avg. Volume1,521
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)0.86
Price to Sales (P/S)1.00
P/FCF Ratio-9.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage reduces refinancing pressure and preserves financial flexibility for operations or investment. This provides resilience during pharmaceutical pricing, regulatory, or demand disruptions, although current returns on equity have weakened.
Asset And Equity ExpansionA growing equity and asset base indicates accumulated financial capacity and supports ongoing manufacturing and distribution activities. This foundation can help the company withstand volatility, provided assets regain their ability to generate consistent earnings.
Positive Revenue GrowthRevenue growth indicates continued demand for the company’s pharmaceutical products across its domestic and export channels. Sustained top-line expansion could improve operating leverage and support recovery, though the broader trend has been uneven.
Bears Say
Profitability Turned NegativeThe shift from solid profits to a net and operating loss signals material margin pressure or higher costs. If persistent, weaker profitability can reduce reinvestment capacity and undermine the value of the company’s expanded asset base.
Negative Operating And Free Cash FlowSustained negative operating and free cash flow may reflect working-capital strain or weaker cash earnings quality. Continued deterioration could increase funding needs and limit financial flexibility despite the company’s currently low leverage.
Uneven Revenue And Weaker ReturnsUneven revenue performance makes demand and earnings recovery less predictable. At the same time, weaker returns on equity indicate that the balance-sheet expansion is currently producing less profit, increasing pressure to improve execution and margins.
Albert David Ltd News
ALBERTDAVD FAQ
What was Albert David Ltd’s price range in the past 12 months?
Albert David Ltd lowest stock price was ₹581.30 and its highest was ₹925.00 in the past 12 months.
What is Albert David Ltd’s market cap?
Albert David Ltd’s market cap is ₹4.90B.
When is Albert David Ltd’s upcoming earnings report date?
Albert David Ltd’s upcoming earnings report date is Nov 09, 2026 which is in 63 days.
How were Albert David Ltd’s earnings last quarter?
Albert David Ltd released its earnings results on Aug 06, 2026. The company reported ₹56.066 earnings per share for the quarter.
Is Albert David Ltd overvalued?
According to Wall Street analysts Albert David Ltd’s price is currently Overvalued.
Does Albert David Ltd pay dividends?
Albert David Ltd pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.58%. See more information on Albert David Ltd dividends here
What is Albert David Ltd’s EPS estimate?
Albert David Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Albert David Ltd have?
Albert David Ltd has 5,707,162 shares outstanding.
What happened to Albert David Ltd’s price movement after its last earnings report?
Albert David Ltd reported an EPS of ₹56.066 in its last earnings report. Following the earnings report the stock price went up 4.452%.
Which hedge fund is a major shareholder of Albert David Ltd?
Currently, no hedge funds are holding shares in IN:ALBERTDAVD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Albert David Ltd
Albert David Limited is an Indian pharmaceutical company specializing in the production and distribution of a diverse array of medical products. Its offerings encompass pharmaceutical formulations, intravenous solutions, herbal medicines, bulk drug substances, and disposable medical devices like syringes and needles. The company's formulations address various therapeutic areas, including injectable medications (parenterals), oral and enteral drugs, topical applications, and vision care products. In addition to its operations within India, Albert David Limited actively exports its products to markets across Latin America, Southeast Asia, and different African nations. The company, established in 1938, is headquartered in Kolkata, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Glenmark Pharmaceuticals Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
IPCA Laboratories Limited
―
Unichem Laboratories Limited
―